Better Buy: AbbVie vs. Eli Lilly
The COVID-19 pandemic has spared few companies, but AbbVie (NYSE: ABBV) and Eli Lilly (NYSE: LLY) are two pharma giants whose businesses are thriving amid the ongoing crisis. Both drugmakers have also performed better than the broader market of late. Year to date, shares of AbbVie are up by 3.2%, while Eli Lilly's stock is up by 17.8%. By contrast, the S&P 500 is down by about 8% since the year started. Both AbbVie and Eli Lilly could continue to outperform the market moving forward, but which of these two pharma stocks is the better buy today?
Source Fool.com